MAINZ BIOMED NV (MYNZ) Stock Price, Quote, News and Overview

What is the stock price of MAINZ BIOMED NV today?

The current stock price of MYNZ is 5.07 USD. The price decreased by -3.06% in the last trading session.

What is the ticker symbol for MAINZ BIOMED NV stock?

The exchange symbol of MAINZ BIOMED NV is MYNZ and it is listed on the Nasdaq exchange.

On which exchange is MYNZ stock listed?

MYNZ stock is listed on the Nasdaq exchange.

What is the price forecast or stock price prediction for MAINZ BIOMED NV stock?

6 analysts have analysed MYNZ and the average price target is 14.28 USD. This implies a price increase of 181.66% is expected in the next year compared to the current price of 5.07. Check the MAINZ BIOMED NV stock analysts ratings, price target forecast and up-and down grades for more detailed information.

What is MAINZ BIOMED NV worth?

MAINZ BIOMED NV (MYNZ) has a market capitalization of 11.26M USD. This makes MYNZ a Nano Cap stock.

How many employees does MAINZ BIOMED NV have?

MAINZ BIOMED NV (MYNZ) currently has 68 employees.

What are the support and resistance levels for MAINZ BIOMED NV (MYNZ) stock?

MAINZ BIOMED NV (MYNZ) has a resistance level at 5.88. Check the full technical report for a detailed analysis of MYNZ support and resistance levels.

Is MAINZ BIOMED NV (MYNZ) expected to grow?

The Revenue of MAINZ BIOMED NV (MYNZ) is expected to grow by 12.87% in the next year. Check the estimates tab for more information on the MYNZ EPS, Sales, EBIT and EBITDA future analyst estimates.

Should I buy MAINZ BIOMED NV (MYNZ) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:

• The Technical Analysis (TA) tab contains a technical analysis of MYNZ, looking at technical quality and support and resistance levels
• The Fundamental Analysis (FA) tab contains a fundamental analysis of MYNZ, evaluating the profitability, health, valuation and growth aspects
• MAINZ BIOMED NV (MYNZ) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
• MAINZ BIOMED NV (MYNZ) Sales and EPS estimates to see what analysts future expectations are.
• MAINZ BIOMED NV (MYNZ) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
• MAINZ BIOMED NV (MYNZ) Insider and Institutional Ownership to learn about the owners and their transactions.
• MAINZ BIOMED NV (MYNZ) Stock Chart to make your own analysis
• MAINZ BIOMED NV (MYNZ) Latest news and press-releases to stay up to date.

Does MAINZ BIOMED NV (MYNZ) stock pay dividends?

MYNZ does not pay a dividend.

When does MAINZ BIOMED NV (MYNZ) report earnings?

MAINZ BIOMED NV (MYNZ) will report earnings on 2025-04-07, after the market close.

What is the Price/Earnings (PE) ratio of MAINZ BIOMED NV (MYNZ)?

MAINZ BIOMED NV (MYNZ) does not have a PE ratio as the earnings reported over the last twelve months were negative (-48.05).

What is the Short Interest ratio of MAINZ BIOMED NV (MYNZ) stock?

The outstanding short interest for MAINZ BIOMED NV (MYNZ) is 1.66% of its float. Check the ownership tab for more information on the MYNZ short interest.

ChartMill assigns a fundamental rating of 2 / 10 to MYNZ. Both the profitability and financial health of MYNZ have multiple concerns.

Over the last trailing twelve months MYNZ reported a non-GAAP Earnings per Share(EPS) of -48.05. The EPS decreased by -3381.64% compared to the year before.

ChartMill assigns a Buy % Consensus number of 43% to MYNZ. The Buy consensus is the average rating of analysts ratings from 6 analysts.

For the next year, analysts expect an EPS growth of 63.45% and a revenue growth 12.87% for MYNZ